2019 Symposium

2018 Symposium

2017 Symposium

2016 Symposium

2015 Symposium

2014 Symposium

2013 Symposium

Previous Symposia

2014 Featured Talks » Androgen Receptor Signaling Axis on CRPC – The A to Z in Drug Development



Part One

Part Two

Androgen Receptor Signaling Axis on CRPC – The A to Z in Drug Development


NamPhuong Tran, MD
Janssen R&D




NamPhuong Tran, MD
Director Clinical Research
Janssen R&D


Dr. Tran is a Director of Clinical Research at Janssen R&D. She joined Cougar Biotechnology in 2008 to work on the abiraterone acetate Clinical Development Program in the area of Prostate Cancer. After the acquisition of Cougar Biotechnology by Johnson & Johnson in 2009, Dr. Tran continued her work in Prostate cancer serving as clinical study leader for many of the Phase I and II abiraterone acetate clinical trials. Currently she is the clinical study leader for an active large Janssen global abiraterone acetate phase III study in the metastatic hormone-naïve prostate cancer.

Dr. Tran earned her MD degree from Stanford University School of Medicine. She completed her Internal Medicine Residency at Stanford and her Oncology fellowship at USCF.